The global vitamin D testing market is expected to
grow at a CAGR of 32.36% over 2013 to 2018. One of the key factors contributing
to the market’s growth is the increase in aging and chronically ill patient populations
worldwide. The global vitamin D testing market has also witnessed an increase
in product approvals.
The global vitamin D testing market is
experiencing a significant increase in product approvals for leading vendors.
For instance, Qualigen Inc. received the FDA approval for FastPack Vitamin D
Immunoassay for use on its proprietary FastPack System for the rapid
determination of vitamin D status and Gold Standard Diagnostics Corp. obtained
the FDA clearance for its 25-OH Vitamin D Total ELISA test in July 2013. Moreover,
DiaSorin received the FDA clearance for its newly developed LIAISON 25 OH
Vitamin D TOTAL assay in February 2012. These product approvals are expected to
have a positive impact on the growth of the market.
A major driver influencing the growth of the global
vitamin D testing market is the increase in the aging and chronically ill
populations worldwide. The majority of the global population is prone to
several diseases as a result of changes in their lifestyles and food habits. This
increases the demand for various diagnostic procedures, including vitamin D
testing. Presently, vitamin D deficiency is associated with several diseases
such as cancer, diabetes, heart attack and depression. That apart, one of the other
major challenges involves the stringent regulatory approval process for vitamin
D testing devices that leads to delayed approval of such devices.
For further
insights, Global Vitamin D Testing Market
About
Research on Global Markets
Research on Global Markets is a leading source for
market research on various sectors globally offering premium research content
from worldwide publishers of market research reports.
To know more about our services, connect with us: support@researchonglobalmarkets.com
No comments:
Post a Comment